Bank OZK’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank OZK’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$629K	Hold	3,972	–	–	0.19%	98
2026 Q1	$507K	Hold	3,972	–	–	0.18%	102
2025 Q4	$484K	Hold	3,972	–	–	0.17%	110
2025 Q3	$398K	Hold	3,972	–	–	0.14%	110
2025 Q2	$329K	Hold	3,972	–	–	0.13%	117
2025 Q1	$322K	Hold	3,972	–	–	0.13%	115
2024 Q4	$358K	Sell	3,972 -244	-6%	-$23.6K	0.15%	110
2024 Q3	$417K	Buy	4,216 +52	+1%	+$5.11K	0.17%	105
2024 Q2	$386K	Buy	4,164 +85	+2%	+$7.62K	0.17%	109
2024 Q1	$387K	Sell	4,079 -28	-0.7%	-$2.6K	0.17%	109
2023 Q4	$367K	Sell	4,107 -2,345	-36%	-$174K	0.18%	112
2023 Q3	$471K	Sell	6,452 -407	-6%	-$32.5K	0.26%	98
2023 Q2	$571K	Sell	6,859 -53	-0.8%	-$4.43K	0.27%	92
2023 Q1	$527K	Hold	6,912	–	–	0.26%	82
2022 Q4	$574K	Buy	6,912 +2,855	+70%	+$231K	0.28%	82
2022 Q3	$322K	Buy	+4,057	New	+$342K	0.17%	100
2022 Q2	–	Sell	-2,480	Closed	-$223K	–	126
2022 Q1	$223K	Buy	2,480 +179	+8%	+$16.5K	0.1%	119
2021 Q4	$258K	Buy	+2,301	New	+$278K	0.11%	115
2019 Q4	–	Sell	-10,250	Closed	-$781K	–	135
2019 Q3	$781K	Buy	10,250 +605	+6%	+$50.3K	0.34%	66
2019 Q2	$846K	Buy	9,645 +2,155	+29%	+$184K	0.37%	62
2019 Q1	$678K	Buy	7,490 +330	+5%	+$28.1K	0.3%	75
2018 Q4	$514K	Buy	7,160 +3,265	+84%	+$263K	0.26%	82
2018 Q3	$373K	Buy	3,895 +50	+1%	+$4.85K	0.15%	105
2018 Q2	$366K	Buy	+3,845	New	+$353K	0.14%	104

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Bank OZK's XBI Position: Q2 2026 in Review

Bank OZK held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 3,972 shares worth $629K. The position accounts for 0.19% of the portfolio, ranked #98.

Bank OZK first reported a position in XBI in Q2 2018 and has held it in 24 quarters since. The position peaked at $846K in Q2 2019. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Bank OZK held 3,972 shares of State Street SPDR S&P Biotech ETF worth $629K as of Q2 2026.
Bank OZK left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.19% of Bank OZK's portfolio in Q2 2026, its #98 holding.
Bank OZK first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 24 quarters since.
Bank OZK's State Street SPDR S&P Biotech ETF position peaked at $846K in Q2 2019.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bank OZK's 13F filing for Q2 2026, filed 17 Aug 2026.